[Proton pump inhibitors in paediatrics].
In last years the use in the pediatric area of proton pump inhibitors (omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole) is more often, nevertheless the clinical trials carried out are poor. The aim of this work is to analyse the bibliography published about this kind of drugs in children and to make a revision of its use in the last seven years. More studies with omeprazole and lansoprazole have been developed, to be exact omeprazole and lansoprazole is present in 122 bibliographic appointments and 34 for lansoprazole, which include studies that demonstrate a good tolerance and efficacy. The remaining proton pump inhibitors count with very few studies. The main therapeutic indications were the eradication of Helicobacter pylori, gastroesophageal reflux disease and esophagitis. The number of patients included in the reviewed studies is quite heterogeneous, from 8 to 122 and the age range between 8 days and 17 years. On the other hand, it could be highlighted the non-existence of formulations adapted to the pediatric population and the difficulty of administration specially in the youngest patients. As in many other drugs, it would be necessary to carry out clinical trials in order to determinate the pharmacologic parameters at difference ages, which will allow a safe and effective administration, and its authorization by all Health Authorities.
Carcelén Andrés
J
J
Grupo Español de Farmacia Pediátrica, SEFH. jca@grupobbva.net
Barroso Péez
C
C
Fábrega Bosacoma
C
C
Feal Cortizas
B
B
Gallego Lago
V
V
Hidalgo Albert
E
E
Pozas del Río
M T
MT
Revert Molina-Niñirola
A
A
Valderde Molina
E
E
Wood Wood
M A
MA
D054328:Proton Pump Inhibitors
D054328:Proton Pump Inhibitors